Non-Executive Director Opportunity – Clinical Stage Biotech – Biotechnology – Vaccines
Our client is a clinical-stage biotech developing a universal influenza vaccine which is about to enter phase I as well as developing other immunotherapies against serious infectious diseases and cancer. They were created as a spinoff from a commercial-stage vaccine company by its CEO and R&D leadership team in June 2017.
With over 4M€ of capital raised since inception, the objective of our client is to sell a licence of its universal influenza vaccine in 2022. They are planning to raise a Series A in 2019 and are willing to strengthen their Board of Directors prior to doing so.
Our client is strong on the basic science, scientific partnerships, clinical development, early-stage fundraising, and European corporate development. Their gaps are in their knowledge of the US market and exposure to US investors.
The profile of the NED candidate is therefore as follows:
- Prior experience as Non Executive Board Director of a US-based Biotech company
- Prior experience in infectious diseases, ideally in vaccines
- Prior exposure to US-based investors in the field of Biotech, in an Executive or Non-Executive position
- Passionate about the science, and willing to ‘give back’ for a high-impact project in terms of public health
Some experience with large pharma companies would be a plus